Biotech

All Articles

A better examine Brutal Biotech's Ferocious 15

.Within this full week's incident of "The Best Pipe," our company're diving in to Fierce Biotech's y...

Lilly experiences period 2 failure of tau-targeting med

.The confetti is still flying coming from Eli Lilly's celebration celebrating the approval of Alzhei...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings and...

Lykos will certainly inquire FDA to reexamine its selection following denial of MDMA therapy for trauma

.Complying with a bad revealing for Lykos Therapies' MDMA candidate for trauma at a current FDA advi...

AN 2 fifty percents head count, ceases period 3 trial after records dissatisfy

.AN2 Rehabs is rethinking its business in feedback to poor midphase data, pledging to lay off half i...

Merck pays for $700M for bispecific, spying autoimmune opening as well as possibility to test Amgen in cancer cells

.Merck &amp Co. is paying for $700 thousand in advance to test Amgen in a blood cancer market. The b...

Gilead pays for J&ampJ $320M to exit licensing offer for seladelpar

.Along With Gilead Sciences on the verge of an FDA choice for its own liver health condition drug se...

' All hands on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks may observe the business establishing camping tents at basecamp...

Entero laying off team, vacating workplace and pausing R&ampD

.Cushion Liquidators has actually transformed Entero Therapeutics white as a piece. The financial in...

Exelixis goes down ADC after deciding it is actually no match for Tivdak

.Exelixis is giving up on its own cells aspect (TF)- targeting antibody-drug conjugate after ending ...